00897.HK
Wai Yuen Tong Medicine Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.34
−8.11%Year over year
Reported trailing growth
- Revenue
- -8.3%
- EBITDA
- +6.8%
- EBIT
- +66.4%
- EPS
- -42.9%
- Free cash flow
- -2.1%
- Operating cash flow
- -13.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -19.0%
- EBITDA
- -16.7%
- EBIT
- +46.1%
- Net income
- -43.8%
- EPS
- -42.9%
- Free cash flow
- -0.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026